Mesenchymal stem cells (MSCs) have the potential to differentiate into multiple connective tissue lineages and secrete paracrine molecules that have immunomodulatory, anti-fibrotic, and angiogenic effects. This makes them a promising therapeutic option for a variety of diseases. A new study has found that cryo-preserved and unfrozen bone marrow MSCs have comparable biological signatures. This is important because it means that cryopreservation can be used to store and transport MSCs without compromising their quality or efficacy. The study analyzed data from approximately 2300 stem cell manufacturing cases, including 60 variables, such as viability, population doubling time (PDT), immunophenotyped, and soluble paracrine molecules. After statistical analysis, the researchers found no significant differences between cryo-preserved and unfrozen MSCs in terms of viability, PDT, immunophenotyped, or paracrine molecule production. This study provides strong evidence that cryo-preserved bone marrow MSCs are comparable to unfrozen MSCs in terms of their biological signatures. This is a significant finding that could facilitate the development and delivery of MSC-based therapies to patients in need.
Related Posts
What triggers juvenile diabetes?
It is unknown what specifically causes type 1 diabetes. However, the immune system of the body, which typically targets dangerous bacteria and viruses, accidentally kills the insulin-producing (islet) cells in the pancreas in the majority of individuals with type 1 diabetes. It seems that both genetics and environmental factors are involved in this process. Although […]
Springtails: The First Animals with Antifreeze Proteins
Springtails are tiny, insect-like animals that can be found almost everywhere on Earth. But what makes springtails truly special is that they are the first animals known to have developed antifreeze proteins. Antifreeze proteins are proteins that help to prevent the formation of ice crystals. This is important for springtails, which live in cold climates […]
Advances in metastatic breast cancer treatments bring hope and improved survival.
Treatments for metastatic breast cancer have played a pivotal role in reducing mortality rates. Advances in targeted therapies, hormone therapies, and immunotherapies have improved the effectiveness of treatments, slowing disease progression and enhancing overall survival. Early detection, personalized treatment plans, and a multidisciplinary approach have also contributed. Patients now benefit from a more comprehensive understanding […]